{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:39:57Z","timestamp":1790746797311,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41375-025-02684-6","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T10:17:04Z","timestamp":1752315424000},"page":"2246-2255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Aberrant splicing of CHEK1 is a driver of megakaryocytic dysplasia in U2AF1S34F mutant myelodysplastic neoplasms"],"prefix":"10.1038","volume":"39","author":[{"given":"Wenjun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8291-9883","authenticated-orcid":false,"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiejun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0147-2291","authenticated-orcid":false,"given":"Zefeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8876-0802","authenticated-orcid":false,"given":"Lihong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7550-8832","authenticated-orcid":false,"given":"Zhijian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"key":"2684_CR1","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1056\/NEJMra1904794","volume":"383","author":"M Cazzola","year":"2020","unstructured":"Cazzola M. Myelodysplastic syndromes. N Engl J Med. 2020;383:1358\u201374.","journal-title":"N Engl J Med"},{"key":"2684_CR2","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1182\/blood-2018-10-844621","volume":"133","author":"S Ogawa","year":"2019","unstructured":"Ogawa S. Genetics of MDS. Blood. 2019;133:1049\u201359.","journal-title":"Blood"},{"key":"2684_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41586-022-04785-z","volume":"606","author":"MA Fabre","year":"2022","unstructured":"Fabre MA, de Almeida JG, Fiorillo E, Mitchell E, Damaskou A, Rak J, et al. The longitudinal dynamics and natural history of clonal haematopoiesis. Nature. 2022;606:335\u201342.","journal-title":"Nature"},{"key":"2684_CR4","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ccell.2023.04.006","volume":"41","author":"IA van Zeventer","year":"2023","unstructured":"van Zeventer IA, de Graaf AO, Salzbrunn JB, Nolte IM, Kamphuis P, Dinmohamed A, et al. Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population. Cancer Cell. 2023;41:1017\u201331.","journal-title":"Cancer Cell"},{"key":"2684_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev-biochem-091719-064225","volume":"89","author":"ME Wilkinson","year":"2020","unstructured":"Wilkinson ME, Charenton C, Nagai K. RNA splicing by the spliceosome. Annu Rev Biochem. 2020;89:359\u201388.","journal-title":"Annu Rev Biochem"},{"key":"2684_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature10496","volume":"478","author":"K Yoshida","year":"2011","unstructured":"Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011;478:64\u20139.","journal-title":"Nature"},{"key":"2684_CR7","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1038\/s41375-022-01718-7","volume":"36","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wu J, Qin T, Xu Z, Qu S, Pan L, et al. Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms. Leukemia. 2022;36:2875\u201382.","journal-title":"Leukemia"},{"key":"2684_CR8","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1172\/JCI91363","volume":"127","author":"BH Yip","year":"2017","unstructured":"Yip BH, Steeples V, Repapi E, Armstrong RN, Llorian M, Roy S, et al. The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes. J Clin Invest. 2017;127:2206\u201321.","journal-title":"J Clin Invest"},{"key":"2684_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109626","volume":"36","author":"SP Kim","year":"2021","unstructured":"Kim SP, Srivatsan SN, Chavez M, Shirai CL, White BS, Ahmed T, et al. Mutant U2AF1-induced alternative splicing of H2afy (macroH2A1) regulates B-lymphopoiesis in mice. Cell Rep. 2021;36:109626.","journal-title":"Cell Rep"},{"key":"2684_CR10","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1158\/2159-8290.CD-21-0508","volume":"12","author":"EC Wheeler","year":"2022","unstructured":"Wheeler EC, Vora S, Mayer D, Kotini AG, Olszewska M, Park SS, et al. Integrative RNA-omics discovers GNAS alternative splicing as a phenotypic driver of splicing factor-mutant neoplasms. Cancer Discov. 2022;12:836\u201355.","journal-title":"Cancer Discov"},{"key":"2684_CR11","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391\u2013405.","journal-title":"Blood"},{"key":"2684_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/978-1-61779-307-3_18","volume":"788","author":"G Tolhurst","year":"2012","unstructured":"Tolhurst G, Carter RN, Miller N, Mahaut-Smith MP. Purification of native bone marrow megakaryocytes for studies of gene expression. Methods Mol Biol. 2012;788:259\u201373.","journal-title":"Methods Mol Biol"},{"key":"2684_CR13","doi-asserted-by":"crossref","unstructured":"Feng G, Gale RP, Cui W, Cai W, Huang G, Xu Z, et al. A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes. Exp Hematol Oncol. 2016;5:12.","DOI":"10.1186\/s40164-016-0041-6"},{"key":"2684_CR14","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1182\/blood-2004-02-0769","volume":"104","author":"A Tomer","year":"2004","unstructured":"Tomer A. Human marrow megakaryocyte differentiation: multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes. Blood. 2004;104:2722\u20137.","journal-title":"Blood"},{"key":"2684_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exphem.2017.10.001","volume":"57","author":"S Mazzi","year":"2018","unstructured":"Mazzi S, Lordier L, Debili N, Raslova H, Vainchenker W. Megakaryocyte and polyploidization. Exp Hematol. 2018;57:1\u201313.","journal-title":"Exp Hematol"},{"key":"2684_CR16","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1182\/blood-2008-03-144956","volume":"112","author":"L Lordier","year":"2008","unstructured":"Lordier L, Jalil A, Aurade F, Larbret F, Larghero J, Debili N, et al. Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho\/Rock signaling. Blood. 2008;112:3164\u201374.","journal-title":"Blood"},{"key":"2684_CR17","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.devcel.2011.12.019","volume":"22","author":"Y Gao","year":"2012","unstructured":"Gao Y, Smith E, Ker E, Campbell P, Cheng E-c, Zou S, et al. Role of RhoA-specific guanine exchange factors in regulation of endomitosis in megakaryocytes. Dev Cell. 2012;22:573\u201384.","journal-title":"Dev Cell"},{"key":"2684_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.lfs.2014.04.011","volume":"106","author":"X Yang","year":"2014","unstructured":"Yang X, Xu W, Hu Z, Zhang Y, Xu N. Chk1 is required for the metaphase\u2013anaphase transition via regulating the expression and localization of Cdc20 and Mad2. Life Sci. 2014;106:12\u20138.","journal-title":"Life Sci"},{"key":"2684_CR19","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1091\/mbc.E14-11-1563","volume":"26","author":"DR Mackay","year":"2015","unstructured":"Mackay DR, Ullman KS, Solomon MJ. ATR and a Chk1-Aurora B pathway coordinate postmitotic genome surveillance with cytokinetic abscission. Mol Biol Cell. 2015;26:2217\u201326.","journal-title":"Mol Biol Cell"},{"key":"2684_CR20","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1083\/jcb.201902085","volume":"218","author":"J Michelena","year":"2019","unstructured":"Michelena J, Gatti M, Teloni F, Imhof R, Altmeyer M. Basal CHK1 activity safeguards its stability to maintain intrinsic S-phase checkpoint functions. J Cell Biol. 2019;218:2865\u201375.","journal-title":"J Cell Biol"},{"key":"2684_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.canlet.2020.09.016","volume":"497","author":"F Neizer-Ashun","year":"2021","unstructured":"Neizer-Ashun F, Bhattacharya R. Reality CHEK: understanding the biology and clinical potential of CHK1. Cancer Lett. 2021;497:202\u201311.","journal-title":"Cancer Lett"},{"key":"2684_CR22","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2018-04-843771","volume":"132","author":"A Pellagatti","year":"2018","unstructured":"Pellagatti A, Armstrong RN, Steeples V, Sharma E, Repapi E, Singh S, et al. Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes\/pathways and clinical associations. Blood. 2018;132:1225\u201340.","journal-title":"Blood"},{"key":"2684_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccell.2018.07.003","volume":"34","author":"SC-W Lee","year":"2018","unstructured":"Lee SC-W, North K, Kim E, Jang E, Obeng E, Lu SX, et al. Synthetic lethal and convergent biological effects of cancer-associated spliceosomal gene mutations. Cancer cell. 2018;34:225\u201341.","journal-title":"Cancer cell"},{"key":"2684_CR24","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","volume":"365","author":"E Papaemmanuil","year":"2011","unstructured":"Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D, et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med. 2011;365:1384\u201395.","journal-title":"N Engl J Med"},{"key":"2684_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1158\/0008-5472.CAN-23-3038","volume":"84","author":"PL Moura","year":"2024","unstructured":"Moura PL, Mortera-Blanco T, Hofman IJ, Todisco G, Kretzschmar WW, Bj\u00f6rklund A-C, et al. Erythroid differentiation enhances RNA mis-splicing in SF3B1-mutant myelodysplastic syndromes with ring sideroblasts. Cancer Res. 2024;84:211\u201325.","journal-title":"Cancer Res"},{"key":"2684_CR26","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1182\/blood.2023020078","volume":"142","author":"RP Hasserjian","year":"2023","unstructured":"Hasserjian RP, Germing U, Malcovati L. Diagnosis and classification of myelodysplastic syndromes. Blood. 2023;142:2247\u201357.","journal-title":"Blood"},{"key":"2684_CR27","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1182\/blood.2021012652","volume":"139","author":"CA Clough","year":"2022","unstructured":"Clough CA, Pangallo J, Sarchi M, Ilagan JO, North K, Bergantinos R, et al. Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome. Blood. 2022;139:2038\u201349.","journal-title":"Blood"},{"key":"2684_CR28","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ccell.2015.04.006","volume":"27","author":"E Kim","year":"2015","unstructured":"Kim E, Ilagan Janine O, Liang Y, Daubner Gerrit M, Lee Stanley CW, Ramakrishnan A, et al. SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition. Cancer cell. 2015;27:617\u201330.","journal-title":"Cancer cell"},{"key":"2684_CR29","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1172\/JCI125022","volume":"129","author":"WB Dalton","year":"2019","unstructured":"Dalton WB, Helmenstine E, Walsh N, Gondek LP, Kelkar DS, Read A, et al. Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation. J Clin Invest. 2019;129:4708\u201323.","journal-title":"J Clin Invest"},{"key":"2684_CR30","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1158\/0008-5472.CAN-21-1843","volume":"82","author":"KM Lappin","year":"2022","unstructured":"Lappin KM, Barros EM, Jhujh SS, Irwin GW, McMillan H, Liberante FG, et al. Cancer-associated SF3B1 mutations confer a BRCA-like cellular phenotype and synthetic lethality to PARP inhibitors. Cancer Res. 2022;82:819\u201330.","journal-title":"Cancer Res"},{"key":"2684_CR31","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1158\/0008-5472.CAN-23-3239","volume":"84","author":"ZS Liu","year":"2024","unstructured":"Liu ZS, Sinha S, Bannister M, Song A, Arriaga-Gomez E, McKeeken AJ, et al. R-loop accumulation in spliceosome mutant leukemias confers sensitivity to PARP1 inhibition by triggering transcription-replication conflicts. Cancer Res. 2024;84:577\u201397.","journal-title":"Cancer Res"},{"key":"2684_CR32","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1016\/j.molcel.2024.04.006","volume":"84","author":"S Benbarche","year":"2024","unstructured":"Benbarche S, Pineda JMB, Galvis LB, Biswas J, Liu B, Wang E, et al. GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignancies. Mol Cell. 2024;84:1886\u2013903.","journal-title":"Mol Cell"},{"key":"2684_CR33","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1038\/leu.2016.149","volume":"30","author":"H Dolatshad","year":"2016","unstructured":"Dolatshad H, Pellagatti A, Liberante FG, Llorian M, Repapi E, Steeples V, et al. Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes. Leukemia. 2016;30:2322\u201331.","journal-title":"Leukemia"},{"key":"2684_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.molcel.2019.07.017","volume":"76","author":"J Zhang","year":"2019","unstructured":"Zhang J, Ali AM, Lieu YK, Liu Z, Gao J, Rabadan R, et al. Disease-causing mutations in SF3B1 alter splicing by disrupting interaction with SUGP1. Mol Cell. 2019;76:82\u201395.","journal-title":"Mol Cell"},{"key":"2684_CR35","doi-asserted-by":"publisher","first-page":"10305","DOI":"10.1073\/pnas.1922622117","volume":"117","author":"Z Liu","year":"2020","unstructured":"Liu Z, Zhang J, Sun Y, Perea-Chamblee TE, Manley JL, Rabadan R. Pan-cancer analysis identifies mutations in SUGP1 that recapitulate mutant SF3B1 splicing dysregulation. Proc Natl Acad Sci USA. 2020;117:10305\u201312.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2684_CR36","doi-asserted-by":"publisher","first-page":"eabn5135","DOI":"10.1126\/scitranslmed.abn5135","volume":"15","author":"SA Mian","year":"2023","unstructured":"Mian SA, Philippe C, Maniati E, Protopapa P, Bergot T, Piganeau M, et al. Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia. Sci Transl Med. 2023;15:eabn5135.","journal-title":"Sci Transl Med"},{"key":"2684_CR37","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1038\/s41375-022-01674-2","volume":"36","author":"C Garcia-Ruiz","year":"2022","unstructured":"Garcia-Ruiz C, Mart\u00ednez-Valiente C, Cord\u00f3n L, Liquori A, Fern\u00e1ndez-Gonz\u00e1lez R, Pericuesta E, et al. Concurrent Zrsr2 mutation and Tet2 loss promote myelodysplastic neoplasm in mice. Leukemia. 2022;36:2509\u201318.","journal-title":"Leukemia"},{"key":"2684_CR38","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.molcel.2016.04.011","volume":"62","author":"SM Park","year":"2016","unstructured":"Park SM, Ou J, Chamberlain L, Simone TM, Yang H, Virbasius CM, et al. U2AF35(S34F) promotes transformation by directing aberrant ATG7 pre-mRNA 3\u2019 end formation. Mol Cell. 2016;62:479\u201390.","journal-title":"Mol Cell"},{"key":"2684_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.devcel.2014.12.015","volume":"32","author":"M Trakala","year":"2015","unstructured":"Trakala M, Rodriguez-Acebes S, Maroto M, Symonds CE, Santamaria D, Ortega S, et al. Functional reprogramming of polyploidization in megakaryocytes. Dev Cell. 2015;32:155\u201367.","journal-title":"Dev Cell"},{"key":"2684_CR40","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1158\/2643-3230.BCD-23-0230","volume":"5","author":"M Sarchi","year":"2024","unstructured":"Sarchi M, Clough CA, Crosse EI, Kim J, Baquero Galvis LD, Aydinyan N, et al. Mis-splicing of mitotic regulators sensitizes SF3B1-mutated human HSCs to CHK1 inhibition. Blood Cancer Discov. 2024;5:353\u201370.","journal-title":"Blood Cancer Discov"},{"key":"2684_CR41","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1083\/jcb.201304054","volume":"201","author":"KR Machlus","year":"2013","unstructured":"Machlus KR, Italiano JE Jr. The incredible journey: from megakaryocyte development to platelet formation. J Cell Biol. 2013;201:785\u201396.","journal-title":"J Cell Biol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02684-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02684-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02684-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T06:29:51Z","timestamp":1757226591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02684-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2684"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02684-6","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The patient gave written informed consent compliant with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}